Nexosome Oncology Invested 2021

Nexosome Oncology is focused on the applications of exosome-based diagnostics in the cancer field.  Findings to date confirm that employing an exosome-focused liquid biopsy approach to cancer can reveal fingerprints of the ever-changing molecular machinery of tumor cells, including information that can help predict and evaluate responsiveness and resistance to therapeutics.

Visit https://www.nexosome-oncology.com